Brief: Sygnis signs distribution agreement with Lucigen
03/12/2015 11:00
Dec 3 (Reuters) - Sygnis AG LIO1k.DE :
* Has signed a distribution agreement with Lucigen Corp. for commercialization of Sygnis'
proprietary product portfolio in USA
* Has granted Lucigen non-exclusive rights to promote, market, and sell all existing and
future sygnis product lines in U.S.
* Lucigen will focus on clinical oncology research market where no-bias single cell
amplification is of critical importance for NGS applications
Source text for Eikon: ID:nEQ5S96HSa
Further company coverage: LIO1k.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))